Fasciitis and myositis: An analysis of muscle-related complications caused by chronic GVHD after allo-SCT

Bone Marrow Transplantation

Volumn 43, Issue 2, 2009, Pages 159-167

  Oda, K ^a   Nakaseko, C ^a   Ozawa, S ^a   Nishimura, M ^a   Saito, Y ^a   Yoshiba, F ^b   Yamashita, T ^c   Fujita, H ^d   Takasaki, H ^d,e   Kanamori, H ^e   Maruta, A ^e   Sakamaki, H ^c   Okamoto, S ^f  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KANAGAWA CANCER CENTER   (Japan)

^f KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; EARLY DIAGNOSIS; FASCIITIS; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; FASCIITIS; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; MYOSITIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59549083592     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.297     Document Type: Article

References (27)

1. Armitage JO. Bone marrow transplantation. N Engl J Med 1994; 330: 827-838.
2. Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA et al. Risk factors for chronic graft-versus- host disease after HLA-identical sibling bone marrow transplantation. Blood 1990; 75: 2459-2464.
3. Farag SS. Chronic graft-versus-host disease: Where do we go from here? Bone Marrow Transplant 2004; 33: 569-577.
4. Ozawa S, Nakaseko C, Nishimura M, Maruta A, Cho R, Ohwada C et al. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: Incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. Br J Haematol 2007; 137: 142-151.
5. Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999; 341: 14-21.
6. Duell T, van Lint MT, Ljungman P, Tichelli A, Socie G, Apperley JF et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 1997; 126: 184-192.
7. Janin A, Socie G, Devergie A, Aractingi S, Esperou H, Verola O et al Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases. Ann Intern Med 1994; 120: 993-998.
8. Markusse HM, Dijkmans BA, Fibbe WE. Eosinophilic fasciitis after allogeneic bone marrow transplantation. J Rheumatol 1990; 17 692-694.
9. van den Bergh V, Tricot G, Fonteyn G, Dom R, Bulcke J. Diffuse fasciitis after bone marrow transplantation. Am J Med 1987; 83: 139-143.
10. Parker P, Chao NJ, Ben-Ezra J, Slatkin N, Openshaw H, Niland JC et al Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine (Baltimore) 1996; 75: 279-285.
11. Stevens AM, Sullivan KM, Nelson JL. Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology (Oxford) 2003; 42: 34-39.
12. Couriel DR, Beguelin GZ, Giralt S, De Lima M, Hosing C, Kharfan-Dabaja MA et al. Chronic graft-versus-host disease manifesting as polymyositis: An uncommon presentation. Bone Marrow Transplant 2002; 30: 543-546.
13. Tse S, Saunders EF, Silverman E, Vajsar J, Becker L, Meaney B. Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease. Bone Marrow Transplant 1999; 23: 397-399.
14. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
15. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-347.
16. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-407.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
18. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154.
19. Goldstein R, Duvic M, Targoff IN, Reichlin M, McMenemy AM, Reveille JD et al. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum 1990; 33: 1240-1248.
20. Sato N, Okamoto S, Mori T, Watanabe R, Hamano Y, Kawamura J et al. Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia. Hematology 2002; 7: 109-112.
21. Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: Long-term follow-up of a randomized trial. Blood 2002; 100: 415-419.
22. Atsuta Y, Suzuki R, Yamamoto K, Terakura S, Iida H, Kohno A et al. Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant 2006; 37: 289-296.
23. Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S et al. Performance of a new clinical grading system for chronic graft-versus-host disease: A multicenter study. Blood 2003; 102 802-809.
24. Kojima K, Kurokawa MS, Tanimoto K, Kojima Y, Hara M, Yoshino T et al Clonal expansion of limited T cell clonotypes in affected muscle from a patient with post-transplant polymyositis. Bone Marrow Transplant 2002; 30: 467-470.
25. Leano AM, Miller K, White AC. Chronic graft-versus-host disease-related polymyositis as a cause of respiratory failure following allogeneic bone marrow transplant. Bone Marrow Transplant 2000; 26: 1117-1120.
26. Stephenson AL, Mackenzie IR, Levy RD, Road J. Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness. Thorax 2001; 56: 82-84.
27. Ustun C, Ho Jr G. Eosinophilic fasciitis after allogeneic stem cell transplantation: A case report and review of the literature. Leuk Lymphoma 2004; 45: 1707-1709.